photo of

Details

Role Director
Group Director's Office
Professor Kathryn North AC BSc(Med) MBBS MD DMedSc FRACP FAHMS

Professor Kathryn North AC is Director of the Murdoch Children’s Research Institute and the David Danks Professor of Child Health Research at the University of Melbourne.

Professor North is trained as a physician, neurologist and clinical geneticist and in 1994, was awarded a doctorate for research in neurogenetics. She completed a postdoctoral fellowship in the Harvard Genetics Program.

Professor North is a national and international leader in Genomic medicine. In 2014, Professor North was appointed as Co-Chair of the Global Alliance for Genomics and Health - a collaborative network of over 500 organisations across over 100 countries funded by the NIH and the Wellcome Trust (genomicsandhealth.org). Commencing in 2016, she leads an NHMRC-funded national network of over 80 institutions - the Australian Genomics Health Alliance (AGHA). The goal of AGHA is to provide evidence and practical strategies for the implementation of genomic medicine in the Australian health system.

Professor North chaired the National Health and Medical Research Council Research Committee from 2012-2018, and has chaired the International Advisory Board of the Great Ormond Street Institute of Child Health (UK) since 2015. She is a member of the Board of the Victorian Comprehensive Cancer Centre. In 2014, she was appointed as a Foundation fellow of the Australian Academy of Health and Medical Science, and in 2020 joined the Academy’s Board. In 2020, she joined the Board of the Association of Australian Medical Research Institutes (AAMRI) as President-Elect.

Professor North has received a number of awards including the GSK Australia Award for Research Excellence (2011), the Ramaciotti Medal for Excellence in Biomedical Research (2012) and Member of the Order of Australia (AM) for service to medicine in the field of neuromuscular and neurogenetics research (2012). In 2019, Professor North was appointed a Companion of the Order of Australia (AC), for eminent service to genomic medicine internationally, to medical research in the field nationally and of genetics, neurology and child health, and as a mentor and role model.
Professor Kathryn North AC BSc(Med) MBBS MD DMedSc FRACP FAHMS

Professor Kathryn North AC is Director of the Murdoch Children’s Research Institute and the David Danks Professor of Child Health Research at the University of Melbourne.

Professor...
Professor Kathryn North AC BSc(Med) MBBS MD DMedSc FRACP FAHMS

Professor Kathryn North AC is Director of the Murdoch Children’s Research Institute and the David Danks Professor of Child Health Research at the University of Melbourne.

Professor North is trained as a physician, neurologist and clinical geneticist and in 1994, was awarded a doctorate for research in neurogenetics. She completed a postdoctoral fellowship in the Harvard Genetics Program.

Professor North is a national and international leader in Genomic medicine. In 2014, Professor North was appointed as Co-Chair of the Global Alliance for Genomics and Health - a collaborative network of over 500 organisations across over 100 countries funded by the NIH and the Wellcome Trust (genomicsandhealth.org). Commencing in 2016, she leads an NHMRC-funded national network of over 80 institutions - the Australian Genomics Health Alliance (AGHA). The goal of AGHA is to provide evidence and practical strategies for the implementation of genomic medicine in the Australian health system.

Professor North chaired the National Health and Medical Research Council Research Committee from 2012-2018, and has chaired the International Advisory Board of the Great Ormond Street Institute of Child Health (UK) since 2015. She is a member of the Board of the Victorian Comprehensive Cancer Centre. In 2014, she was appointed as a Foundation fellow of the Australian Academy of Health and Medical Science, and in 2020 joined the Academy’s Board. In 2020, she joined the Board of the Association of Australian Medical Research Institutes (AAMRI) as President-Elect.

Professor North has received a number of awards including the GSK Australia Award for Research Excellence (2011), the Ramaciotti Medal for Excellence in Biomedical Research (2012) and Member of the Order of Australia (AM) for service to medicine in the field of neuromuscular and neurogenetics research (2012). In 2019, Professor North was appointed a Companion of the Order of Australia (AC), for eminent service to genomic medicine internationally, to medical research in the field nationally and of genetics, neurology and child health, and as a mentor and role model.

Top Publications

  • Papadimitriou, ID, Lockey, SJ, Voisin, S, Herbert, AJ, Garton, F, Houweling, PJ, Cieszczyk, P, Maciejewska-Skrendo, A, Sawczuk, M, Massidda, M, et al. No association between ACTN3 R577X and ACE I/D polymorphisms and endurance running times in 698 Caucasian athletes. BMC Genomics 19(1) : 13 2018
    view publication
  • Cline, MS, Liao, RG, Parsons, MT, Paten, B, Alquaddoomi, F, Antoniou, A, Baxter, S, Brody, L, Cook-Deegan, R, Coffin, A, et al. BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.. PLoS Genet 14(12) : e1007752 2018
    view publication
  • Thangarajh, M, Elfring, GL, Trifillis, P, McIntosh, J, Peltz, SW, Ryan, MM, Kornberg, AJ, RodriguezCasero, V, Wray, A, Jones, KJ, et al. The relationship between deficit in digit span and genotype in nonsense mutation Duchenne muscular dystrophy. Neurology 91(13) : e1215 -e1219 2018
    view publication
  • Chisholm, AK, Anderson, VA, Pride, NA, Malarbi, S, North, KN, Payne, JM. Social Function and Autism Spectrum Disorder in Children and Adults with Neurofibromatosis Type 1: a Systematic Review and Meta-Analysis. Neuropsychology Review 28(3) : 317 -340 2018
    view publication
  • Pride, NA, Barton, B, Hutchins, P, Coghill, DR, Korgaonkar, MS, Hearps, SJC, Rouel, M, Malarbi, S, North, KN, Payne, JM. Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial. BMJ Open 8(8) : e021800 2018
    view publication